Search research articles
Contact Us
Filters
Showing results (1-10 of 65) with videos related to
Page
of 7
Sort By:
Lancet (London, England)
|
October 7, 1997
Simplified vs complex adjuvant chemotherapy schedule for osteosarcoma
R H Blum
Biography
|
January 1, 1981
Psychological processes in preparing contemporary biography
R H Blum
The American Journal of Orthopsychiatry
|
July 1, 1973
Drugs and public policy. Let the punishment eclipse the crime
R H Blum
Cancer Treatment Reviews
|
September 1, 1988
Hypothesis: a new basis for sensory-behavioral pretreatments to ameliorate radiation therapy-induced nausea and vomiting?
R H Blum
Oncology (Williston Park, N.Y.)
|
December 12, 1997
Clinical status and optimal use of the cardioprotectant, dexrazoxane
R H Blum
Cancer Treatment Reports
|
March 1, 1978
Maytansine: a phase I study of an ansa macrolide with antitumor activity
R H Blum, T Kahlert
CA: a Cancer Journal for Clinicians
|
November 1, 1974
New chemotherapeutic agents--bleomycin and adriamycin
S K Carter, R H Blum
Annals of Internal Medicine
|
February 1, 1974
Adriamycin. A new anticancer drug with significant clinical activity
R H Blum, S K Carter
Progress in Biochemical Pharmacology
|
January 1, 1976
Current status of American studies with bleomycin
S K Carter, R H Blum
American Journal of Clinical Oncology
|
August 1, 1989
A phase III randomized trial of epirubicin versus 5-fluorouracil in metastatic rectal/sigmoid adenocarcinoma
P Molinaro, F Lafleur, R H Blum
Page
of 7
Search research articles
Search
Showing results (1-10 of 65) with videos related to
Sort By:
Page
of 7
Lancet (London, England)
|
October 7, 1997
Simplified vs complex adjuvant chemotherapy schedule for osteosarcoma
R H Blum
Biography
|
January 1, 1981
Psychological processes in preparing contemporary biography
R H Blum
The American Journal of Orthopsychiatry
|
July 1, 1973
Drugs and public policy. Let the punishment eclipse the crime
R H Blum
Cancer Treatment Reviews
|
September 1, 1988
Hypothesis: a new basis for sensory-behavioral pretreatments to ameliorate radiation therapy-induced nausea and vomiting?
R H Blum
Oncology (Williston Park, N.Y.)
|
December 12, 1997
Clinical status and optimal use of the cardioprotectant, dexrazoxane
R H Blum
Cancer Treatment Reports
|
March 1, 1978
Maytansine: a phase I study of an ansa macrolide with antitumor activity
R H Blum, T Kahlert
CA: a Cancer Journal for Clinicians
|
November 1, 1974
New chemotherapeutic agents--bleomycin and adriamycin
S K Carter, R H Blum
Annals of Internal Medicine
|
February 1, 1974
Adriamycin. A new anticancer drug with significant clinical activity
R H Blum, S K Carter
Progress in Biochemical Pharmacology
|
January 1, 1976
Current status of American studies with bleomycin
S K Carter, R H Blum
American Journal of Clinical Oncology
|
August 1, 1989
A phase III randomized trial of epirubicin versus 5-fluorouracil in metastatic rectal/sigmoid adenocarcinoma
P Molinaro, F Lafleur, R H Blum
Page
of 7